BA
OM icon

Bridgewater Associates’s Outset Medical OM Stock Holding History

Bridgewater Associates’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,905
Closed -$637K – 792
2023
Q3 		$637K Buy
3,905
+409
+12% +$96.5K ﹤0.01% 669
2023
Q2 		$1.15M Sell
3,496
-405
-10% -$124K 0.01% 554
2023
Q1 		$1.08M Buy
3,901
+138
+4% +$50.7K 0.01% 554
2022
Q4 		$1.46M Sell
3,763
-1,259
-25% -$355K 0.01% 585
2022
Q3 		$1.2M Buy
5,022
+14
+0.3% +$3.75K 0.01% 666
2022
Q2 		$1.12M Buy
5,008
+486
+11% +$209K ﹤0.01% 784
2022
Q1 		$3.08M Buy
4,522
+1,085
+32% +$653K 0.01% 589
2021
Q4 		$2.38M Buy
3,437
+501
+17% +$371K 0.01% 436
2021
Q3 		$2.18M Sell
2,936
-219
-7% -$149K 0.01% 425
2021
Q2 		$2.37M Buy
+3,155
New +$2.41M 0.02% 465

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Bridgewater Associates's OM Position: Q4 2023 in Review

Bridgewater Associates sold out of Outset Medical (OM) in Q4 2023, closing a stake of 3,905 shares — an estimated $637K sold.

Bridgewater Associates first reported a position in OM in Q2 2021 and held it in 10 quarters. The position peaked at $3.08M in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Bridgewater Associates reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Bridgewater Associates sold 3,905 Outset Medical shares in Q4 2023, an estimated $637K.
  • Bridgewater Associates first reported a position in Outset Medical in Q2 2021 and held it in 10 quarters.
  • Bridgewater Associates's Outset Medical position peaked at $3.08M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.